Sara B. Calvert

1.0k total citations
20 papers, 663 citations indexed

About

Sara B. Calvert is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Sara B. Calvert has authored 20 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Public Health, Environmental and Occupational Health, 8 papers in Economics and Econometrics and 4 papers in General Health Professions. Recurrent topics in Sara B. Calvert's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Health and Medical Research Impacts (3 papers) and Medication Adherence and Compliance (3 papers). Sara B. Calvert is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Health and Medical Research Impacts (3 papers) and Medication Adherence and Compliance (3 papers). Sara B. Calvert collaborates with scholars based in United States, United Kingdom and Switzerland. Sara B. Calvert's co-authors include Kevin J. Anstrom, Kevin Flaherty, João A. de Andrade, Craig S. Glazer, Robert J. Kaner, Imre Noth, Mitchell A. Olman, Judith A. Stafford, Nancy M. Allen LaPointe and Lisa A. Kaltenbach and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Sara B. Calvert

19 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara B. Calvert United States 10 313 129 127 106 104 20 663
James Grana United States 13 138 0.4× 153 1.2× 47 0.4× 80 0.8× 18 0.2× 16 568
Jeetvan Patel United States 13 179 0.6× 126 1.0× 80 0.6× 14 0.1× 62 0.6× 25 473
Peter Haastrup Denmark 16 176 0.6× 94 0.7× 40 0.3× 28 0.3× 55 0.5× 48 844
Monica Beaulieu Canada 13 100 0.3× 65 0.5× 26 0.2× 31 0.3× 73 0.7× 26 648
Jetty A. Overbeek Netherlands 14 94 0.3× 46 0.4× 89 0.7× 27 0.3× 94 0.9× 57 716
Temitope Olufade United States 11 70 0.2× 97 0.8× 21 0.2× 44 0.4× 144 1.4× 24 571
Sumeet Panjabi United States 14 68 0.2× 106 0.8× 21 0.2× 95 0.9× 205 2.0× 71 565
Carole Ayav France 14 68 0.2× 79 0.6× 22 0.2× 32 0.3× 63 0.6× 55 660
Bingcao Wu United States 15 161 0.5× 63 0.5× 90 0.7× 26 0.2× 177 1.7× 63 690
Miquel Quesada Spain 11 57 0.2× 87 0.7× 30 0.2× 29 0.3× 258 2.5× 21 627

Countries citing papers authored by Sara B. Calvert

Since Specialization
Citations

This map shows the geographic impact of Sara B. Calvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara B. Calvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara B. Calvert more than expected).

Fields of papers citing papers by Sara B. Calvert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara B. Calvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara B. Calvert. The network helps show where Sara B. Calvert may publish in the future.

Co-authorship network of co-authors of Sara B. Calvert

This figure shows the co-authorship network connecting the top 25 collaborators of Sara B. Calvert. A scholar is included among the top collaborators of Sara B. Calvert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara B. Calvert. Sara B. Calvert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corneli, Amy, et al.. (2025). Adoption of Decentralized Trial Elements in Cancer Clinical Trials Supporting FDA Approvals during COVID-19. Clinical Cancer Research. 31(10). 1827–1830. 2 indexed citations
2.
Corneli, Amy, Kevin McKenna, Richardae Araojo, et al.. (2023). Enhancing Diversity and Inclusion in Clinical Trials. Clinical Pharmacology & Therapeutics. 113(3). 489–499. 31 indexed citations
3.
4.
Nelson, Adam J., Kevin Haynes, Zubin J. Eapen, et al.. (2022). High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.. Journal of the American College of Cardiology. 79(18). 1802–1813. 87 indexed citations
5.
Nanna, Michael G., Adam J. Nelson, Kevin Haynes, et al.. (2022). Lipid‐lowering treatment among older patients with atherosclerotic cardiovascular disease. Journal of the American Geriatrics Society. 71(4). 1243–1249. 6 indexed citations
6.
Corneli, Amy, Carrie Dombeck, Kevin McKenna, & Sara B. Calvert. (2021). Stakeholder Experiences with the Single IRB Review Process and Recommendations for Food and Drug Administration Guidance. PubMed. 43(3). 26–36. 9 indexed citations
7.
Mitchel, Jules T., Nicolle M. Gatto, John C. Laschinger, et al.. (2020). Determining the Suitability of Registries for Embedding Clinical Trials in the United States: A Project of the Clinical Trials Transformation Initiative. Therapeutic Innovation & Regulatory Science. 55(1). 6–18. 12 indexed citations
8.
Corneli, Amy, Sara B. Calvert, John H. Powers, et al.. (2020). Consensus on Language for Advance Informed Consent in Health Care–Associated Pneumonia Clinical Trials Using a Delphi Process. JAMA Network Open. 3(5). e205435–e205435. 2 indexed citations
9.
Kaufmann, Petra, et al.. (2019). Resources to assist in the transition to a single IRB model for multisite clinical trials. Contemporary Clinical Trials Communications. 15. 100423–100423. 3 indexed citations
10.
Corneli, Amy, Zachary Hallinan, Brian Perry, et al.. (2018). The Clinical Trials Transformation Initiative: Methodology supporting the mission. Clinical Trials. 15(1_suppl). 13–18. 16 indexed citations
11.
Corneli, Amy, Brian Perry, Deborah Collyar, et al.. (2018). Assessment of the Perceived Acceptability of an Early Enrollment Strategy Using Advance Consent in Health Care–Associated Pneumonia. JAMA Network Open. 1(8). e185816–e185816. 5 indexed citations
12.
Morse, Jessica E., et al.. (2018). Evidence-based pregnancy testing in clinical trials: Recommendations from a multi-stakeholder development process. PLoS ONE. 13(9). e0202474–e0202474. 6 indexed citations
13.
Stergiopoulos, Stella, Sara B. Calvert, Carrie Brown, et al.. (2017). Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial. Clinical Infectious Diseases. 66(1). 72–80. 13 indexed citations
14.
Stergiopoulos, Stella, et al.. (2015). Cost Drivers of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase Three Clinical Trials. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations
15.
Noth, Imre, Kevin J. Anstrom, Sara B. Calvert, et al.. (2012). A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(1). 88–95. 317 indexed citations
16.
Calvert, Sara B., Judith M. Kramer, Kevin J. Anstrom, et al.. (2012). Patient-focused intervention to improve long-term adherence to evidence-based medications: A randomized trial. American Heart Journal. 163(4). 657–665.e1. 70 indexed citations
17.
LaPointe, Nancy M. Allen, Fang‐Shu Ou, Sara B. Calvert, et al.. (2011). Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome. American Heart Journal. 161(5). 855–863. 46 indexed citations
18.
LaPointe, Nancy M. Allen, Fang‐Shu Ou, Sara B. Calvert, et al.. (2010). Changes in beliefs about medications during long-term care for ischemic heart disease. American Heart Journal. 159(4). 561–569. 23 indexed citations
19.
Burris, H.A., Suzanne F. Jones, Sara B. Calvert, et al.. (2006). Summary of results in patients with metastatic renal cell cancer (RCC) from phase I studies of RAD001 (everolimus). Journal of Clinical Oncology. 24(18_suppl). 14599–14599. 9 indexed citations
20.
Joy, Salini Scaria, et al.. (2003). Assessment of therapeutic interventions and degree of glycemic control for patients with Type 2 Diabetes mellitus using preprandial versus postprandial self blood glucose monitoring in a primary care setting. 1. 96–97. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Grana Breakdown of academic impact, for papers by Jeetvan Patel Breakdown of academic impact, for papers by Peter Haastrup Breakdown of academic impact, for papers by Monica Beaulieu Breakdown of academic impact, for papers by Jetty A. Overbeek Breakdown of academic impact, for papers by Temitope Olufade Breakdown of academic impact, for papers by Sumeet Panjabi Breakdown of academic impact, for papers by Carole Ayav Breakdown of academic impact, for papers by Bingcao Wu Breakdown of academic impact, for papers by Miquel Quesada
Rankless by CCL
2026